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Saudi Journal of Ophthalmology (2012) 26, 271–275Pediatric Ophthalmology UpdateUpdate of intraocular lens implantation in childrenMohammed Al Shamrani, MD ⇑; Shahira Al Turkmani, MDAbstractCataract is a common problem that affects the vision in children and a major cause of amblyopia in children. However, the man-
agement of childhood cataract is tenuous and requires special considerations especially with regard to intraocular lens (IOL)
implantation. Age at which an IOL can be implanted is a controversial issue. Implanting an IOL in very young children carries
the risk of severe postoperative inflammation and posterior capsule opacification that may need other surgeries and may affect
the vision permanently. Accuracy of the calculated IOL power is affected by the short eyes and the steep keratometric values
at this age. Furthermore, choosing an appropriate IOL power is not a straight forward decision as future growth of the eye affects
the axial length and keratometry readings which may result in an unexpected refractive error as children age. The aim of this review
is to cover these issues regarding IOL implantation in children; indications, timing of implantation, types of IOLs, site of implan-
tation and the power calculations.
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Congenital cataract is the most common cause of treat-
able childhood blindness. It is responsible for 5–20% of the
cases of blindness worldwide. However, the incidence of vi-
sual impairment may be higher in developing countries.1
Management of congenital cataract is a challenge and sur-
gery remains an important part of the management. Tech-
niques for managing pediatric cataracts, methods for
calculating intraocular lens (IOL) power and surgical instru-
ments and techniques for IOL implantation have steadily
advanced.
A number of factors may influence the surgical outcome
including: patient age; type of cataract; laterality; timing of
surgery; technical surgical aspect; changing refraction; func-
tional outcome and amblyopia; choice of aphakia correction
and IOL implantation; the active lens epithelial cells and
resultant posterior capsular opacification (PCO); the pres-Peer review under responsibility
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against cystoid macular edema (CME); and finally parental
care and compliance.1–3
Surgery for congenital visually significant cataract must be
performed as early as possible to prevent irreversible ambyl-
opia and the timing of surgery needs to balance the effect on
visual development and the surgical risks.4 Recently, refined
surgical techniques and options for optical correction of
aphakia improved both the technical and functional out-
comes of pediatric cataract surgery. Optical correction in-
cludes aphakic glasses, contact lenses and primary IOL
implantation. Each of the options has its own advantages
and disadvantages.
The capability of the IOL to provide a constant visual stim-
ulus, led to the acceptance of IOL implantation as an alter-
nate form of optical correction. Despite controversy,3 IOLs
are implanted in infants with increasing frequency. Some
have advocated surgery based on age as follows:Production and hosting by Elsevier
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primary posterior capsulectomy and anterior vitrectomy.
IOL implantation in children less than 6 months is still
controversial.
2.Primary IOL implantation is to be the standard of care in
patients over two years of age. There is increasing evi-
dence of safety in those less than 2 years.4
Surgery for unilateral congenital cataracts that present
during the first 6 months of life remains the most challenging
in terms of timing of surgery, surgical technique and choice of
IOL. A survey by the American Association for Pediatric Oph-
thalmology and Strabismus reported an increase in IOL
implantation in children less than 2 years from 12.9% to
81.9% from 1993 to 2001. Some have advocated implanting
IOLs at an even younger age less than 6 months in cases of
unilateral cataract with no contraindications such as microp-
thalmia or structural abnormality.5
Outcomes of IOL implantation in children
Ledoux et al. reported a 14 year retrospective review of
239 children (aged 11 days to 17 years), with unilateral and
bilateral cataracts who underwent primary IOL implantation.6
They found approximately 75% achieved 20/40 vision or bet-
ter and with better outcomes in bilateral cases and in children
who were older than 1 year prior to IOL implantation.6 In a
retrospective study of 400 patients with 87% of the cohort
undergoing primary IOL implantation, Congdon et al. re-
ported that 40% achieved 20/60 vision or better.7 Congdon
et al. concluded that IOL implantation with spectacle correc-
tion predicted a better visual outcome.7 Factors associated
with a worse visual outcome included previous surgery,
post-op complication, unilateral cases and female sex.7 A
study of primary IOL implantation in 120 eyes of 80 children
below 2 years of age concluded that IOLs were safe and can
be considered a viable option for visual rehabilitation.7
Relative contraindications of primary IOL implantation in
children include, corneal diameter less than 9 mm, extremely
microphthalmic eyes, and a poorly formed anterior segment
structure.Selection of IOL
The choice of IOL is the most contentious issue and in-
cludes factors such as primary versus secondary IOL implan-
tation, biometry and IOL calculation, safety profile of the
IOL and the targeted refraction postoperatively. In terms of
the type of IOL and the safety profile, foldable hydrophobic
acrylic IOL (Acrysof; Alcon Laboratories Inc., Fort Worth,
TX, USA) material is preferred.8 Some have recommended
the Acrysof SA series for in the bag fixation.9 For example,
Acrysof (SA series) implantation resulted in well maintained
centration, minimal inflammation, less severe PCO and was
well tolerated in pediatric eyes.10
Current practice favors the use of a single-piece IOL due
to the flexible haptics and excellent memory. Implantation
of a single piece IOL is not technically challenging, does
not deform and adapts to the smallest capsular bag without
decentration.10 A foldable hydrophobic single-piece IOL had
been introduced that can be implanted through a 1.9 mm
corneal incision. This IOL has been implanted in 32 eyesand showed comparable postoperative visual acuity and inci-
dence of PCO as other acrylic IOLs up to 29 months
postoperatively.11
Recently, a study of multifocal IOL implantation in older
children (2 years to 16 years; 35 eyes) expressed cautious
optimism about safety and efficacy.12 Multifocal IOLs require
precise measurements, calculations, and accurate positioning
for optimal performance. Multifocal IOLs can increase glare
and decrease contrast sensitivity. Larger studies and longer
follow up are required to justify the use of multifocal IOLs
in children.9Biometry & IOL calculations
Axial length measurements
A small difference in axial length measurement may result
in clinically significant residual refractive error. For example, a
0.1 mm difference in axial length may result in 0.25–0.75 D
difference in IOL calculation. In shorter eyes of children, the
error could be magnified to 14 D/mm.13 Axial length can
be measured using ultrasound or optical biometry. Axial
length can be measured using contact or immersion ultraso-
nography. These two techniques are performed under gen-
eral anesthesia for children with cataract. However,
performing these measurements under general anesthesia in-
creases the error by misdirection of the ultrasound from the
fovea which is the ideal direction to measure the axial length.
A retrospective comparison of IOL implantation by Ben-Zion
et al. compared a group of children whose axial length was
measured with the contact technique to another group that
underwent the immersion technique and found no difference
in the predicted refractive error.14 A recent prospective study
on 50 cataractous eyes of 50 children (mean age,
3.87 ± 3.72 years) by Trivedi and Wilson found that the axial
length was shorter in eyes with contact ultrasonography com-
pared to immersion ultrasonography (21.36 ± 3.04 mm vs.
21.63 ± 3.09 mm respectively; P < 0.001).15 In 16 eyes of in-
fants with axial length less than 20 mm, contact measure-
ments were longer than the immersion technique in 31.2%
compared to 8.8% in infants with axial length greater than
20 mm. This indicates that errors are more likely in eyes less
than 20 mm long.15 Additionally, the anterior chamber depth
was statistically significantly shallower with the contact tech-
nique compared to the immersion technique
(P < 0.001).15This difference is related to unavoidable inden-
tation with the contact technique.
Optical biometry is based on partial coherence interfer-
ometry (PCI) and requires patient cooperation and visibility
of posterior pole. There are currently three commercially
available optical biometers. The first commercially available
PCI biometer was the IOL Master (Carl Zeiss AG, Jena, Ger-
many), then the Lenstar (Haag Streit AG, Koeniz, Switzerland)
and very recently, the AL-Scan (NIDEK Co. Ltd., Gamagori,
Japan) was introduced. IOL Master for axial length measure-
ments in children is repeatable and accurate.16–18 In a pro-
spective study of 20 patients, Hussin et al. found that axial
length measurement with PCI was 0.017 mm longer than con-
tact ultrasound; however this difference was not statistically
significant.16 In this repeatable study, the test-retest differ-
ence was longer with A-scan ultrasound than PCI at 0.042
and 0.004, respectively.16
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Regression formulas were derived from a retrospective
analysis of data of a large cohort of adult patients who had
undergone surgery. These regression formulas were further
modified to correct the calculation errors due to the axial
length that falls outside the normal range. The Hoffer Q
and Holladay 2 formulas were reported to be more accurate
for shorter adult eyes.19–22 The accuracy of different IOL cal-
culation formulas in children has been previously studied. For
example, Andreo et al., found that the absolute prediction
error in individual eyes tends to be similar for Holladay I, Hof-
fer Q and SRK T formulas.23 Neely et al. used SRK II, SRK T,
Hoffer Q and Holladay 1 to recalculate the IOL power for
101 patients who had undergone surgery at mean age of
4.8 years and found that the mean prediction error was
0.3 ± 1.5 D.24 There was no significant difference in the pre-
dictability of the lens power between these four formulas
and the newer theoretical formula did not out-perform the
older regression formulas.24 In this study, there was greater
variability in shorter eyes (less than 19 mm), and in children
less than 2 years old.24 The least variable was the SRK II
and the greatest was Hoffer Q.24 This outcome contradicted
a similar study by Nehalani and VanderVeen with a larger
study cohort and shorter eyes (axial length < 22 mm).25
Nehalani and VanderVeen found that Hoffer Q was more pre-
dictable than the other formulas especially in young children
(<2 years old) and in shorter eyes (<22 mm).25 The SRK T,
Holladay I and Hoffer Q were similar in predicting refractive
error within ±1 D. (67.4%, 74.1% and 72.6%, respectively).25
Tromans et al., found the mean predicted refractive error
after IOL implantation using SRK II and SRK T formulas to
be greater in children younger than 36 months (2.56 D vs
1.06 D) and in eyes with axial length less than 20 mm
(2.63 D vs 1.07 D) using the SRK II and SRK T formulas.26
Moore et al. found that age at the time of surgery was signif-
icantly and inversely correlated with the mean absolute value
of the prediction error in a retrospective study on 203 eyes
using the Holladay 1, SRK II and SRK T formulas.27 However
Moore et al.’s study found that keratometry rather than the
axial length was significantly correlated to the mean absolute
value of the predictive error which was 1.08 ± 0.93 D.28 The
Holladay II formula contains seven variables to improve pre-
dictability. These variables are axial length, corneal power,
horizontal cornea diameter, phakic anterior chamber depth,
phakic lens thickness, preoperative refraction and patient
age. Preoperative refraction is rarely available for children
undergoing cataract surgery. Trivedi et al. studied the accu-
racy of Holladay II formula in the absence of preoperative
refraction in 45 eyes (mean age 3.9 ± 2.9; range,0.1 years to
10.4 years).28 They compared the predicted error in the Holl-
aday II formula to Hoffer Q, Holladay I and the SRK T formu-
las.28 The Holladay II formula (without preoperative
refraction) gave the least predicted error of the four formulas
followed by the Hoffer Q formula especially in eyes shorter
than 22 mm.Postoperative targeted refraction
Choosing the targeted immediate postoperative refrac-
tion in children undergoing cataract extraction and IOL
implantation depends on many factors some of which remainunresolved. Immediate postoperative refractive error and its
correction are important factors in preventing amblyopia that
may seriously affect the visual outcome of an excellent sur-
gery. Additionally, the magnitude of myopic shift later in life
may necessitate an IOL exchange. Myopic shift results from
visual deprivation, axial elongation with fixed IOL power
and the change in IOL position as the eye grows. Gimbel et
al. recommended the implantation of an IOL with a power
closer to that predicted for immediate emmetropia, thus
avoiding the risk of ametropic amblyopia in the immediate
postoperative period but the risk of large myopic shift later
in life remains.29 Most of the myopic shift occurs in the first
2–3 years of life. O’Keefe et al. evaluated 27 eyes of children
who had undergone cataract extraction and IOL implantation
in the first year of life.30 They followed this cohort for a mean
of 41 months and found 6 D of myopic shift that occurred
mainly in the first 24 months of life.30 This outcome is very
similar to Dahan and Drusedau study that reported a
6.39 D of myopic shift in patients who had an IOL implanted
at age 1–18 months.31 This is also consistent with a prospec-
tive study by Crouch et al., of children who underwent IOL
implantation between 12 months and 18 years with a mean
follow up of 3 years and there was a myopic shift of
5.69 D in children who underwent surgery in the second
year of life and a shift of 3.66 D when the surgery was per-
formed when the children were between 3 years and 4 years
old.32 The amount of myopic shift decreases as children age,
reaching about 1.00 D when surgery is performed at age
11 years to 14 years.32 In Crouch et al.’s study, the postoper-
ative refractive goal was +4.0 under 2 years, +2.0 to +3.0 in
2 years to 4 years, +1.0 to +2.0 in 4 years to 6 years, plano
to +1.0 in 6 years to 8 years and plano when over 8 years.32
Eighty-five percent of patients achieved best corrected visual
acuity (BCVA) of 20/40 or better, 95% of bilateral patients
had BCVA of 20/30 or better and 74% of unilateral cases
achieved BCVA of 20/50 or better.32 Table 1 summarizes
the recommendation for IOL power selection in different
studies.31–35
In a recent study of pediatric pseudophakes who had
undergone surgery less than 8.5 years of age Lowery et al.
studied the final BCVA of 36 eyes of 26 patients in relation
to the initial pseudophakic refraction with a mean spherical
equivalent of +2.63 ± 2.52 D.36 In bilateral cases the final
BCVA was independent of any reasonable initial pseud-
ophakic refractive error and in unilateral cases the BCVA
was significantly related to the initial pseudophakic refractive
error (irrespective of the fellow eye’s refractive error).36 The
best initial pseudophakic spherical equivalent was from
+1.75 D to + 5.00 D with errors in the myopic direction result-
ing in a larger decline in long-term BCVA than does hypero-
pia.36 This study had few patients less than 2 years of age
making its application to such young children questionable.36
Dahan suggested biometry of parents to help in detecting
any hereditary axial length abnormalities that may influence
the choice of IOL power.37Posterior capsule opacification (PCO)
PCO is the most common complication. The reported risk
maybe as high as 95%.4 It is ambylogenic in children below
6 years.38The possible causes for (PCO) are the presence of
epithelial cells on the anterior capsule, residual epithelial cells
Table 1. Recommendations for intraocular lens power selection for congenital cataract from various studies.
Age at
surgery
(year)
Crouch et al.32
(targeted
postoperative
refraction) (D)
Awner et al.33 (targeted
postoperative refraction) (keeping
the anisometropia less than 3.0 D)
(D)
Hutchinson et al.34
(decrease calculated IOL
power for emmetropia)
(D)
Dorothy35 (decrease
calculated IOL power
for emmetropia) (D)
Dahan and Drusedau31
(of calculated IOL power
for emmetropia) (D) (%)
1 +4.0 +4.0 – 25% (first 6 months) 80
20% (second
6 months)
2 +3.5 +4.0 1.0 D – 90
3 +2.5 +3.0 1.0 D – 90
4 +2.5 +3.0 1.0 D – 90
5 +2.0 +2.0 1.0 D – 90
6 +2.0 +2.0 1.0 D – 90
7 +1.0 +1.0 1.0 D – 90
8 +1.0 +1.0 1.0 D – 90
9 Emmetropia Emmetropia – 90
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is also related to the age of the patient, the degree of post-
operative inflammation and the type of IOL and IOL mate-
rial.4 Aggressive postoperative inflammation may form
secondary membranes across the pupil or over the anterior
or the posterior surface of the IOL that can obscure the visual
axis. PCO can be managed with either pars plana vitrectomy
and capsulotomy or YAG capsulotomy which can be per-
formed under general anesthesia in uncooperative children.4
Repeated treatments may be warranted in some cases. Surgi-
cally, the approach can be anterior via the limbus or posteri-
orly (pars plana).4 Some factors that may reduce the
incidence of PCO include in-the-bag IOL placement, thor-
ough removal of lens substance, hydrodissection, type of
IOL, primary posterior capsulectomy and anterior vitrectomy
(especially in the ambylogenic age group), minimal iris trau-
ma, and minimizing postoperative inflammation.4
In-the-bag IOL placement decreases the risk of IOL dislo-
cation, minimizes decentration, minimizes iris capture and
uveal inflammation and reduces the migration of lens epithe-
lial cells (LECs) from the equatorial zone onto the central pos-
terior capsule.4
Implantation of acrylic IOLs significantly lowers the inci-
dence of PCO. IOLs with a high adhesion property and sharp
optic edge will prevent proliferation of LECs thus mitigating
PCO.4
A primary 3–4 mm posterior capsulectomy and anterior
vitrectomy are associated with decreased PCO and recom-
mended in children below 6 years, uncooperative children
and in eyes that are susceptible to significant postoperative
inflammation.4 Anterior vitrectomy and posterior capsulot-
omy reduce the scaffolding for LECs migration to the anterior
hyaloid face and decrease the incidence of PCO.4Conclusion
Pediatric cataract surgery is evolving with advances in
microsurgical techniques. Currently there is an increasing
trend toward IOL implantation in children with increasing evi-
dence of better visual outcomes in infants managed with IOL
implantation. The accepted minimum age of IOL implanta-
tion is 1–2 years. However, more surgeons are implanting be-
tween 6 months and 1 year. Implanting IOLs at less than
6 months of age is still controversial and under study. IOL
power, calculation and selection represent major conun-drums in these cases. Axial length should be carefully mea-
sured to avoid errors in IOL power calculation. Both
ultrasound and optical biometry can be used for measure-
ment of axial length. The immersion A-scan ultrasound tech-
nique may result in more accurate measurement than contact
ultrasound. There is a lack of agreement on which IOL calcu-
lation formula is more accurate in pediatric cases. The con-
sensus is to leave patients more hyperopic the younger
they are and standardized guidelines have yet to be estab-
lished. Refined surgical techniques, improved IOL material
and design and the use of anti-inflammatory medications
has played a role in decreasing the incidence of PCO and
maintaining a clear visual axis. Realistic expectations of visual
outcome must be explained especially in unilateral cases, late
presentation and poor presenting vision. Finally, surgery rep-
resents a step in the management of cataract in children and
the collaboration between parents and ophthalmologists is
fundamental to achieve optimal visual rehabilitation.References
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